K240348 is an FDA 510(k) clearance for the Quantum Mitohormesis (QMT) (M2101). Classified as Stimulator, Muscle, Powered (product code IPF), Class II - Special Controls.
Submitted by Quantumtx Pte. , Ltd. (Singapore, SG). The FDA issued a Cleared decision on December 19, 2024 after a review of 318 days - an unusually long review period, suggesting complex equivalence evaluation.
This device falls under the Physical Medicine FDA review panel, regulated under 21 CFR 890.5850 - the FDA physical medicine device framework. The Abbreviated 510(k) pathway was used, relying on FDA-recognized standards to demonstrate substantial equivalence.
Device pattern: Standards-based predicate clearance. Standards-verified equivalence. The Abbreviated pathway signals strong alignment with FDA-recognized performance standards - typically associated with lower review burden and faster clearance cycles.
View all Quantumtx Pte. , Ltd. devices